Skip to content
10-K

Annual Report

PURE Bioscience, Inc. PURE

0001493152-24-042939

← back to feed
Filed
Oct 29, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Oct 29, 2024 111.86M sh
Shares Diluted FY 2024 · Jul 31, 2023 111.4M sh
Capex FY 2024 · Jul 31, 2023 $33K
Operating Cash Flow FY 2024 · Jul 31, 2023 −$3.28M
Cash And Equivalents FY 2024 · Jul 31, 2023 $1.1M
Current Liabilities FY 2024 · Jul 31, 2023 $532K
Total Liabilities FY 2024 · Jul 31, 2023 $1.55M
Current Assets FY 2024 · Jul 31, 2023 $1.6M
Total Assets FY 2024 · Jul 31, 2023 $1.83M
Eps Diluted FY 2024 · Jul 31, 2023 −$0.04
Eps Basic FY 2024 · Jul 31, 2023 −$0.04
Sga Expense FY 2024 · Jul 31, 2023 $4.3M
Rd Expense FY 2024 · Jul 31, 2023 $297K
Net Income FY 2024 · Jul 31, 2023 −$3.96M
Operating Income FY 2024 · Jul 31, 2023 −$3.94M
Gross Profit FY 2024 · Jul 31, 2023 $971K
Cost Of Revenue FY 2024 · Jul 31, 2023 $906K
Revenue FY 2024 · Jul 31, 2023 $1.88M
Stockholders Equity FY 2024 · Jul 31, 2022 $3.91M